Ardeshir Rastinehad, DO
Urology · New Hyde Park, NYNPI 1932338514
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,718 of the $28,806 with a category attached, or 75.4%. 6 manufacturers reported payments, led by Boston Scientific at 37.5% of the total. 2025 is the largest year on record at $16,708, 4.1 times the $4,086 reported in 2019. Among urology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $960.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Terumo Medical Corporation$11K
- Philips North America LLC$7K
- Guerbet LLC$500
- Richard Wolf Medical Instruments Corp.$146
- Astellas Pharma US Inc$94
Across 25 payments — averaging $11,025 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Angiodynamics, Inc.$276K
What the payments were for
- Consulting fees$21,71875%
- Speaking & faculty fees$5002%
- Travel & lodging$5,68520%
- Food & beverage$9043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $10,813 |
| Terumo Medical Corporation | 15 | $10,717 |
| Philips North America LLC | 3 | $6,537 |
| Guerbet LLC | 1 | $500 |
| Richard Wolf Medical Instruments Corp. | 1 | $146 |
| Astellas Pharma US Inc | 2 | $94 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$10,543
- Navicross$4,950
- HydroPearl$4,950
- TR Band$3,850
- Uronav$3,672
- (9544) Disease Management Solutions Equip Und$2,840
- Optitorque$2,700
- Heartrail$2,700
- GlideWire$2,250
- Azur CX Detachable$1,697
- Lipiodol$500
- EMBOLD Fibered$222
How this compares
$28,806 in reported general payments places this provider in the 90th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alfuzosin Hcl ErAlfuzosin Hcl | 56 | $1,204 |
| Tamsulosin Hcl | 52 | $828 |
Paid to pharmacies, not to this prescriber.
Other urology in New Hyde Park
- Peter WalterJamestown$1.9M
- Christopher PieczonkaSyracuse$797K
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Jeffrey SpencerCheektowaga$430K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Evan GoldfischerPoughkeepsie$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.